Compounds > losartan
Page last updated: 2024-10-30

losartan and Cataract, Membranous

losartan has been researched along with Cataract, Membranous in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shree, J1
Choudhary, R1
Bodakhe, SH1
Pecci, A1
Granata, A1
Fiore, CE1
Balduini, CL1

Other Studies

2 other studies available for losartan and Cataract, Membranous

ArticleYear
Losartan delays the progression of streptozotocin-induced diabetic cataracts in albino rats.
    Journal of biochemical and molecular toxicology, 2019, Volume: 33, Issue:8

    Topics: Administration, Oral; Administration, Topical; Aldehyde Reductase; Angiotensin II Type 1 Receptor Bl

2019
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:8

    Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors

2008